Alcon (ALC) Long-Term Investments (2009 - 2026)
Alcon (ALC) posted quarterly Long-Term Investments of $800.0 million for Q1 2026, up 4.17% on a QoQ basis from $768.0 million in Q4 2025.
Alcon (ALC) Long-Term Investments (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Long-Term Investments for 11 consecutive years, with $800.0 million the latest figure, recorded in Q1 2026.
- Quarterly Long-Term Investments changed N/A year-over-year to $800.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $800.0 million (changed N/A YoY) and the FY2025 annual result came in at $768.0 million, up 17.79% from the prior year.
- Long-Term Investments advanced to $800.0 million in Q1 2026 per ALC's latest filing, from $768.0 million in the prior quarter.
- Over the last five years, Long-Term Investments for ALC reached as high as $800.0 million in Q1 2026 and fell as low as -$128.0 million in Q4 2024.
- A 5-year average of $482.4 million and a median of $515.5 million in 2023 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments sank 124.76% — and 2025, when it surged 700.0%.
- Year by year, Long-Term Investments stood at $287.0 million in 2022, then jumped by 80.14% to $517.0 million in 2023, then plunged by 124.76% to -$128.0 million in 2024, then jumped by 700.0% to $768.0 million in 2025, then rose by 4.17% to $800.0 million in 2026.
- According to Business Quant data, Long-Term Investments over the past three periods registered $800.0 million, $768.0 million, and $740.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 800.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 3.41 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 207.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | - |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 800.00 Mn |
| Dec 31, 2025 | 768.00 Mn |
| Sep 30, 2025 | 740.00 Mn |
| Jun 30, 2025 | 763.00 Mn |
| Dec 31, 2024 | -128.00 Mn |
| Sep 30, 2024 | 705.00 Mn |
| Jun 30, 2024 | 608.00 Mn |
| Mar 31, 2024 | 589.00 Mn |
| Dec 31, 2023 | 517.00 Mn |
| Sep 30, 2023 | 514.00 Mn |
| Jun 30, 2023 | 513.00 Mn |
| Mar 31, 2023 | 312.00 Mn |
| Dec 31, 2022 | 287.00 Mn |
| Sep 30, 2022 | 263.00 Mn |
| Jun 30, 2022 | 246.00 Mn |
| Mar 31, 2022 | 221.00 Mn |
| Dec 31, 2021 | 217.00 Mn |
| Sep 30, 2021 | 217.00 Mn |
| Jun 30, 2021 | 220.00 Mn |
| Mar 31, 2021 | 216.00 Mn |